0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-07-22 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15850621 2024-07-22 2025-12-31 15850621 2025-12-31 15850621 2024-07-21 15850621 bus:Director1 2024-07-22 2025-12-31 15850621 core:WithinOneYear 2025-12-31 15850621 core:AfterOneYear 2025-12-31 15850621 bus:Micro-entities 2024-07-22 2025-12-31 15850621 bus:AuditExemptWithAccountantsReport 2024-07-22 2025-12-31 15850621 bus:SmallCompaniesRegimeForAccounts 2024-07-22 2025-12-31 15850621 bus:PrivateLimitedCompanyLtd 2024-07-22 2025-12-31 15850621 bus:FullAccounts 2024-07-22 2025-12-31
COMPANY REGISTRATION NUMBER: 15850621
DEVINE PHARMA LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD 22 JULY 2024 TO
31 December 2025
DEVINE PHARMA LTD
STATEMENT OF FINANCIAL POSITION
31 December 2025
Period from
22 Jul 24 to
31 Dec 25
£
Fixed assets
9,578
--------
Current assets
118,263
Prepayments and accrued income
2,290
-----------
120,553
Creditors: amounts falling due within one year
19,117
-----------
Net Current Assets
101,436
-----------
Total Assets Less Current Liabilities
111,014
Creditors: amounts falling due after more than one year
99,233
Accruals and deferred income
1,500
-----------
10,281
-----------
Capital and reserves
10,281
---------
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 17 July 2026 , and are signed on behalf of the board by:
N J Smith
Director
Company registration number: 15850621
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Tower House, Lucy Tower Street, Lincoln, Lincolnshire, LN1 1XW.